Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
N-((4-chlorophenyl)methyl)-N'
and 15 molecules of water
Protionamide has also been tested for use in the treatment of leprosy
an aurora kinase inhibitor CCT137690
LX-4211 Size:Solid 2 mg N-((4-chlorophenyl)methyl)-N'Sotagliflozin, also known as LX4211, is an orally active and a dual SGLT1 SGLT2 inhibitor, which improves glycemic control in patients with type 2 diabetes in a randomized, placebo controlled trial. LX4211 increases serum glucagon like peptide 1 and peptide YY levels by reducing sodium glucose cotransporter 1 (SGLT1) mediated absorption of intestinal glucose. Sotagliflozin is currently being developed by Lexicon for the treatment of type 1 and type 2
US$ 12.95
US$ 12.95
US$ 12.95
US$ 12.95
US$ 16.00
US$ 16.00
US$ 16.00
US$ 16.00
US$ 134.50
US$ 249.50
US$ 30.00
US$ 12.00
US$ 584.50
US$ 109.00
US$ 64.46
US$ 145.00
US$ 12.95
US$ 12.00